ISSN: 1744-6651

Journal Home

Journal Guideline

Expert Review of Endocrinology and Metabolism Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Endocrinology and Metabolism is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism with an H index of 39. It has a price of 4000 €. It has an SJR impact factor of 0,915 and it has a best quartile of Q2. It has an SJR impact factor of 0,915.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Endocrinology, Diabetes and Metabolism (Q2)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Expert Review of Endocrinology and Metabolism

0,915

SJR Impact factor

39

H Index

54

Total Docs (Last Year)

130

Total Docs (3 years)

4189

Total Refs

384

Total Cites (3 years)

121

Citable Docs (3 years)

2.95

Cites/Doc (2 years)

77.57

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Diabetes Q2
European Thyroid Journal Q2
Neuroendocrinology Q2
Pituitary Q2
Diabetes Therapy Q2

Compare this journals

Aims and Scope

Best articles by citations

Cardiovascular complications of diabetes: recent insights in pathophysiology and therapeutics

Novel molecular markers in well-differentiated thyroid cancers

Endocrinopathy of HFE-related hemochromatosis

Pituitary dysfunction after traumatic brain injury: screening and hormone replacement

Hypothalamic-pituitary magnetic resonance imaging in growth hormone deficiency

Cytochrome P450 1A1: is it involved in disruption of thyroid hormone action by polychlorinated biphenyl?

Anti-inflammatory effects of gastric bypass surgery and their association with improvement in metabolic profile

Albiglutide for the management of type 2 diabetes

Glycemic control during critical illness

The potential of selective progesterone receptor modulators for the treatment of uterine fibroids

Thyroid hormone receptor mutations and disease: insights from knock-in mouse models

Long-term metabolic consequences of being born small for gestational age

SHOW MORE ARTICLES

Prenatal glucocorticoid exposure and physiological programming of adult disease

Clinical overview of saxagliptin for Type 2 diabetes management

Tesamorelin for the treatment of excess abdominal fat in HIV-1-infected patients with lipodystrophy

Testosterone, frailty and physical function in older men

A multidisciplinary approach to understanding skeletal dysplasias

Potential for dipeptidyl peptidase-4 inhibitor and sodium glucose cotransporter 2 inhibitor single-pill combinations

Gynecomastia: incidence, causes and treatment

Surgical treatment of nonfunctioning pituitary adenomas

Brain regional thyroid hormone status and Dio3: where genetics, epigenetics and psychiatric vulnerability meet

Impact of genetic screening on the diagnosis and management of medullary thyroid carcinoma

Recommendations for hormone therapy in hysterectomized women: importance of new data in clinical management

Thyroid surgery for treatment of Graves' disease complicated by ophthalmopathy: a comprehensive review